Related references
Note: Only part of the references are listed.Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion
Yi Yang et al.
CANCER RESEARCH (2019)
Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
Nune Markosyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Cancer-Associated Thrombosis: A Two-Way Street
Bal Krishan Sharma et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Dorothea M. Heuberger et al.
THROMBOSIS JOURNAL (2019)
Signaling Crosstalk of TGF-/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer
Hendrik Ungefroren et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Role of indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
Lilla Hornyak et al.
FRONTIERS IN IMMUNOLOGY (2018)
Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice
G. N. Adams et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Derya Kabacaoglu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer A population-based cohort study
Alexander T. Cohen et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
E. Yang et al.
ONCOGENE (2016)
Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity
Kristian M. Hargadon
JOURNAL OF CLINICAL MEDICINE (2016)
Protease-Activated Receptor 1 (PAR-1) Inhibits Proliferation but Enhances Leukemia Stem Cell Activity in Acute Myeloid Leukemia
Susumu Goyama et al.
BLOOD (2016)
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
Rebecca A. Evans et al.
JCI INSIGHT (2016)
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen
Gregory N. Adams et al.
CANCER RESEARCH (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
The role of CD95 and CD95 ligand in cancer
M. E. Peter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes
Peter Tzu-Yu Chien et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2014)
An Efficient Genotyping Method for Genome-modified Animals and Human Cells Generated with CRISPR/Cas9 System
Xiaoxiao Zhu et al.
SCIENTIFIC REPORTS (2014)
Biased signaling of protease-activated receptors
Peishen Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion
Daisuke Fujimoto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Host-Derived MCP-1 and MIP-1 alpha Regulate Protective Anti-Tumor Immunity to Localized and Metastatic B16 Melanoma
Yuko Nakasone et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER CELL (2012)
Thrombin Stimulates Synthesis of Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor by Human Proximal Tubular Epithelial Cells in Culture
Yuko Shimaya et al.
NEPHRON EXTRA (2012)
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006
D. P. Cronin-Fenton et al.
BRITISH JOURNAL OF CANCER (2010)
Signal transduction by protease-activated receptors
Unice J. K. Soh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Protease-activated receptors and prostaglandins in inflammatory lung disease
Terence Peters et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
Eric Yang et al.
CANCER RESEARCH (2009)
Thrombin-Induced Regulation of CD95(Fas) Expression in the N9 Microglial Cell Line: Evidence for Involvement of Proteinase-Activated Receptor1 and Extracellular Signal-Regulated Kinase 1/2
Jonathan R. Weinstein et al.
NEUROCHEMICAL RESEARCH (2009)
Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo
Daxin Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A multicolor panel of novel lentiviral gene ontology (LeGO) vectors for functional gene analysis
Kristoffer Weber et al.
MOLECULAR THERAPY (2008)
PRDM1/BLIMP-1 modulates NN-γ-Dependent control of the MHC class I antigen-processing and peptide-loading pathway
Gina M. Doody et al.
JOURNAL OF IMMUNOLOGY (2007)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
PAR1-mediated NFκB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism
K Tantivejkul et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response
M Steinhoff et al.
ENDOCRINE REVIEWS (2005)
Protease-activated receptors: Contribution to physiology and disease
VS Ossovskaya et al.
PHYSIOLOGICAL REVIEWS (2004)
CD8(+) tumor-infiltrating lymphocytes together with CD4(+) tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
A Fukunaga et al.
PANCREAS (2004)
Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells
R Colognato et al.
BLOOD (2003)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
In vivo evidence for the role of GM-CSF as a mediator in acute pancreatitis-associated lung injury
JL Frossard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Share Paper
